Skip to main content
. 2023 Jan 21;22:9. doi: 10.1186/s12941-023-00557-3

Table 3.

Antimicrobial susceptibility profile of Gram-positive bacteria isolated from asymptomatic primary school children at Debre Berhan town, North Shewa Ethiopia, February 1 to April 30, 2021

Gram negative bacterial isolates Antimicrobials tested
AZM N (%) SXT N (%) CLM N (%) DOX N (%) E N (%) GM N (%) CD N (%) NIT N (%) C N (%) TET N (%) FOX N (%)
S. aureus (73) S 45 (61.6) 18 (24.7) 41 (56.2) 8 (11) 39 (53.4) 37 (50.7) 48 (65.8) 26 (31.8) 28 (38.4) 8 (11) 15 (20.5)
R 28 (39.4) 55 (55.3) 32 (43.8) 65 (89) 34 (46.6) 36 (49.3) 25 (34.2) 49 (67.2) 45 (61.2) 65 (89) 58 (79.5)
CoNS (20) S 12 (60) 6 (30) 13 (65) 5 (25) 11 (55) 13 (65) 11 (55) 5 (75) 5 (75) 2 (10)
R 8 (40) 14 (70) 7 (35) 15 (75) 9 (45) 7 (35) 9 (45) 15 (75) 15 (75) 18 (90)
S. pyogens (10) S 9 (900) 6 (60) 6 (66.7) 9 (90) 5 (66.7) 6 (60)
R 1 (10.0) 4 (40) 4 (33.3) 1 (10.) 5 (33.3) 4 (40)
Total (103) S 66 (64.1) 24 (40.4) 60 (57.3) 30 (31.9) 56 (51.5) 50 (53.2) 68 (65) 31 (33) 33 (32) 17 (15.5) 15 (20.5)
R 38 (35.9) 69 (74.2) 44 (42.7) 80 (86) 50 (48.5) 44 (46.8) 36 (35) 63 (67) 70 (68) 87 (84.5) 58 (79.5)

AZM azithromycin, CIP ciprofloxacin, CRO ceftriaxone, GM gentamicin, SXT trimethoprim-Sulphamethoxazole, CLM clarithromycin, AMP ampicillin, DOX doxycycline, E erythromycin, C chloramphenicol, TET tetracycline, FOX cefoxitin, NIT nitrofurantoin, CD clindamycin